|  |  | Sensitivity | Specificity | ||
---|---|---|---|---|---|---|
Variable | No. of studies | No. of patients | Adjusted (95% CI) | P value | Adjusted (95% CI) | P value |
Study design | ||||||
 Prospective | 4 | 2759 | 0.59 (0.32–0.86) | 0.68 | 0.81 (0.64–0.99) | 0.30 |
 Retrospective | 16 | 141,778 | 0.49 (0.36–0.62) | 0.84 (0.76–0.91) | ||
Study location | ||||||
 USA | 6 | 107,795 | 0.69 (0.53–0.85) | 0.13 | 0.70 (0.52–0.87) | <0.01 |
 Other countries | 14 | 36,742 | 0.42 (0.30–0.54) | 0.87 (0.81–0.93) | ||
No. of patients | ||||||
  ≥ 1500 | 10 | 5424 | 0.39 (0.25–0.54) | 0.13 | 0.89 (0.83–0.95) | 0.84 |
  < 1500 | 10 | 139,113 | 0.62 (0.47–0.77) | 0.74 (0.62–0.86) | ||
Overall mortality, % | ||||||
  ≥ 10% | 10 | 18,715 | 0.54 (0.38–0.70) | 0.68 | 0.77 (0.66–0.89) | 0.01 |
  < 10% | 10 | 125,822 | 0.47 (0.31–0.63) | 0.88 (0.80–0.95) | ||
Location of enrollment | ||||||
 Only ED | 11 | 30,725 | 0.47 (0.31–0.63) | 0.59 | 0.85 (0.76–0.94) | 0.27 |
 Other non-ICU | 9 | 113,812 | 0.55 (0.38–0.72) | 0.81 (0.69–0.92) | ||
Timing of the qSOFA score measurement | ||||||
 At time of initial suspicion of infection | 13 | 124,030 | 0.39 (0.28–0.51) | 0.01 | 0.88 (0.82–0.94) | 0.95 |
 Worst values | 7 | 20,507 | 0.71 (0.57–0.85) | 0.72 (0.56–0.87) | ||
Disease severity | ||||||
 Suspected or confirmed infection | 17 | 142,776 | 0.46 (0.34–0.57) | 0.18 | 0.87 (0.82–0.92) | <0.01 |
 Sepsis or septic shock | 3 | 1761 | 0.74 (0.53–0.96) | 0.49 (0.23–0.76) | ||
Source of infection | ||||||
 Suspected or confirmed infection | 16 | 126,080 | 0.58 (0.47–0.69) | 0.08 | 0.79 (0.70–0.87) | 0.66 |
 Specific infectious entity (community-acquired pneumonia or neutropenic fever) | 4 | 18,457 | 0.24 (0.08–0.40) | 0.94 (0.89–1.00) |